deltatrials

Lille Catholic University Clinical Trials

Sponsors / Lille Catholic University

Lille Catholic University appears as lead sponsor on 90 trial records in ClinicalTrials.gov. The portfolio currently includes 12 recruiting studies, 1 active non-recruiting studies, and 53 completed studies. 8 trials in this portfolio were terminated or withdrawn before completion. The most common reasons cited for termination include slow or insufficient recruitment. Cumulative planned enrollment across all listed trials is 31,441 participants. These counts reflect the current state of the public ClinicalTrials.gov registry.

90
Total Trials
12
Recruiting
1
Other Active
53
Completed
8
Terminated / Withdrawn
31,441
Total Enrollment

Termination reasons: Other50% ยท Recruitment50%

Recent Terminations

  • NCT03643042 Phase NA Stopped Mar 2023
    Myelodysplastic Syndromes
    "The SMD SEUIL TRANSFU study was stopped prematurely because we encountered enrolment difficulties and new treatments are available on the market for patients with RARS or SFR3B1 mutation (Luspatercept)."
  • NCT05164822 Stopped Oct 2022
    Necrotizing Vasculitis
    "insufficient number of inclusions"
  • NCT02874677 Phase NA Stopped Jan 2022
    Multiple Sclerosis
    "material issues in study centres"
  • NCT02587130 Phase PHASE4 Stopped Jan 2019
    Intensive Care
    "difficulted recruiting"
  • NCT02726672 Phase NA Stopped Nov 2018
    Multiple Sclerosis
    "lack of recruitment"
  • NCT02974673 Phase NA Stopped Oct 2018
    Disorder of Ejaculation
    "lack of recruitment"
  • NCT04007133 Stopped Jul 2018
    Non-insulin-dependent Diabetes
    "The study was conducted in the context of a medical thesis with a deadline."
  • NCT02042235 Phase NA Stopped Jan 2018
    Language Development
    "difficulted recruiting"

Active Trials (1 total)

Top Conditions

Top Locations